Up-front F18-FDG PET/CT in suspected salivary gland carcinoma
- 3 Downloads
To investigate whether a 18F-FDG PET/CT (PET/CT)-based diagnostic strategy adds decisive new information compared to conventional imaging in the evaluation of salivary gland tumours and the detection of cervical lymph node metastases, distant metastases, and synchronous cancer in patients with salivary gland carcinoma.
The study was a blinded prospective cohort study. Data were collected consecutively through almost 3 years. All patients underwent conventional imaging—magnetic resonance imaging (MRI) and chest X-ray (CXR)—in addition to PET/CT prior to surgery. Final diagnosis was obtained by histopathology. MRI/CXR and PET/CT were interpreted separately by experienced radiologists and nuclear medicine physicians. Interpretation included evaluation of tumour site, cervical lymph node metastases, distant metastases, and synchronous cancer.
Ninety-one patients were included in the study. Thirty-three patients had primary salivary gland carcinoma and eight had cervical lymph node metastases. With PET/CT, the sensitivity was 92% and specificity 29% regarding tumour site. With MRI/CXR, the sensitivity and specificity were 90% and 26%, respectively. Regarding cervical lymph node metastases in patients with salivary gland carcinoma, the sensitivity with PET/CT was 100% and with MRI/CXR 50%. PET/CT diagnosed distant metastases in five patients, while MRI/CXR detected these in two patients. Finally, PET/CT diagnosed two synchronous cancers, whereas MRI/CXR did not detect any synchronous cancers.
Compared with MRI/CXR PET/CT did not improve discrimination of benign from malignant salivary gland lesions. However, PET/CT may be advantageous in primary staging and in the detection of distant metastases and synchronous cancers.
KeywordsSalivary gland carcinoma Salivary gland tumours PET/CT Diagnostic imaging Staging
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare. The research has been supported as PhD thesis by University of Southern Denmark.
- 5.Barnes L, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours. Lyon: IARC; 2005.Google Scholar
- 10.DAHANCA, Nationale retningslinier for udredning og behandling af spytkirtelkræft i Danmark. 2010, Ver 1.1.Google Scholar
- 12.Okamura T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl. 1998;538:209–13.Google Scholar
- 13.Ozawa N, et al. Retrospective review: usefulness of a number of imaging modalities including CT, MRI, technetium-99 m pertechnetate scintigraphy, gallium-67 scintigraphy and F-18-FDG PET in the differentiation of benign from malignant parotid masses. Radiat Med. 2006;24(1):41–9.CrossRefGoogle Scholar
- 18.Bertagna F, et al. Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: a systematic review. Rev Esp Med Nucl Imagen Mol. 2015;34(5):295–302.Google Scholar
- 22.Roh JL, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48(2):240–6.Google Scholar
- 23.Rubello D, et al. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses. Panminerva Med. 2005;47(3):187–9.Google Scholar
- 30.Cheson BD. Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol. 2015;4(1):5.Google Scholar